2017-11-30 15:47:04 UTC

AGA and Step Therapy Coalition Advocate for Patient Protections

Nov. 30, 2017

Ask your legislator to protect IBD treatment options for your patients.

This week, AGA and members of the Step Therapy Coalition were on Capitol Hill and met with over 20 offices to garner support for Restoring the Patient’s Voice Act (HR 2077), legislation sponsored by Reps. Brad Wenstrup, R-OH, and Raul Ruiz, D-CA, that would provide patients and providers with an equitable and transparent appeals process when subject to step therapy protocols.

We received positive feedback from our coalition meetings and are hoping it translates into an increase in cosponsorship for the legislation. AGA is concerned that a growing number of patients with inflammatory bowel diseases (IBD) who are often treated with biologics are being subjected to step therapy protocols that can have adverse health effects on patients who fail or do not respond positively to the medication that the insurer is forcing them to try.  

The bipartisan legislation would require employer sponsored health plans to do the following:

  • Establish a clear and convenient process for physicians to appeal a step therapy protocol for their patient.
  • Grants patients exceptions to step therapy under five critical circumstances.
  • Expedites care by requiring a timely decision for appeals – three days or 72 hours or within 24 hours if life threatening.

We thank those members who took the time to contact their members of Congress to ask them to cosponsor HR 2077 and if you haven’t already, please call on your legislator to support this legislation

AGA is working closely with the Crohn’s and Colitis Foundation, Arthritis Foundation, Digestive Diseases National Coalition, National Psoriasis Foundation, American Academy of Dermatology, American College of Rheumatology and other partners in generating support for HR 2077. 

More on IBD

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 12, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.